Ny ljusbom – idealisk för användning i krävande miljöer som kyl- och frysanläggningar

OEM Automatic lanserar SH4 Aktiv/Passiv ljusbom från Datasensing, en innovativ lösning för säkerhet inom svensk industri. Den erbjuder enkel installation, kostn...

“Conducting research at universities is becoming more and more like working at a research hotel”

The government wants Swedish research to focus on excellence and innovation, but can the two be combined? Life Science Sweden talks to Anna Falk, a professor at...

Revealing the secrets of a part

CT inspection in automation technology at Festo.

Anna Törner: “My quantified life”

“The expression ‘you can’t see the forest for the trees’ feels newly relevant in the context of wearables. One can easily get caught up in the idea that the mor...

“We should avoid surgery if we can”

Since February this year, she has been Scientific Director Life Science at the Karolinska Institutet. Life Science Sweden met Anna Martling for a talk about rol...

Flödeskontroll med FMQ: Ny effektiv lösning från Anderson-Negele

kostnadseffektiv lösning. När priserna på råvaror, produkter och energi stiger, blir det extra viktigt att se över och effektivisera alla delar av produktionen.

Rickard Sandberg on this year’s Nobel Prize in Medicine: ”A key discovery”

The discovery that paved the way for the development of todays mRNA vaccines is the basis for this year’s Nobel Prize in Physiology or Medicine.

Samuel Lagercrantz: ”Företagen som lyckas med det här tar tätpositionen”

Fokus för utveckling av nya läkemedel och ny medicinteknik bör inte för ensidigt ligga på att förlänga liv. Det är minst lika viktigt att forska fram behandling...

Svenskt CAR-T-bolag fyller på kassan

Elicera Therapeutics, som bland annat utvecklar CAR-T-terapier mot cancer, aviserar en nyemission som kan tillföra bolaget upp till 64 miljoner kronor.

En miljon extra vaccindoser kan nå Sverige i sommar

Uppåt en miljon extra vaccindoser kan nå Sverige i sommar. Orsaken är att flera andra EU-länder börjar bli klara med sina vaccinationsprogram.

Branschen om nya strategin – efterlyser konkretisering

Regeringens uppdaterade life science-strategi får beröm av branschen för sin ambitionsnivå när det gäller förbättrad konkurrenskraft, men samtidigt efterlyses k...

Swedish breakthrough in Alzheimer’s: “We can finally present great data”

Treatments for Alzheimer’s disease are currently among the hottest topics in drug development. Two Swedish research companies with high ambitions and successes in the field participated in Bioscience 2022 conference at Life City in Hagastaden, Stockholm....

Faster development of reliable sample handling

Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...

"Are we doing business the wrong way around in the Life Science Sector?"

For the past 50 years we have created solutions for problems that we thought would solve the problems. Pharmaceuticals have created big block buster drugs which...

Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far

Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...

Column: ”We need to exploit the benefits of the regulations“

You don’t need to search long on the Internet to find lists of the most innovative countries with Sweden ranking at the top. Sweden generally offers good condit...

Södertäljebolag fyller på kassan – satsar på expansion inom diabetes och fetma

Biotechbolaget Nanologica, som producerar insatsvaror för läkemedelsindustrin, ska genomföra en fullt garanterad företrädesemission som ger bolaget ett tillskot...

Samuel Lagercrantz: A special kind of hellishness afflicts post-COVID patients

In addition to the disease itself those suffering from post-COVID have to deal with people who try to label them as hypochondriacs, writes Samuel Lagercrantz in an editorial.

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

Elicera develops CAR-T against solid tumours – may become the first in the world

in that field as well. “It is the largest field, and the potential is enormous,” says the company’s CEO Jamal El-Mosleh.

Biosimilarutvecklare gör nyemission på 343 miljoner

Solnabaserade Xbrane Biopharma aviserar en företrädesemission som fullt tecknad kan tillföra bolaget upp till 343 miljoner kronor.

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Stort vetenskapsmöte igång i Life City

Giulia Gaudenzi: Innovation for good

"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively ...